BEX

BEX is a Japan-based life science tools and contract bioresearch company that develops, manufactures, and sells electroporation and cell-fusion instruments while also providing outsourced molecular biology services. Its core product lines include the CUY21 electroporation systems and LF series cell fusion and nuclear transfer devices, which are used for in vivo, in vitro, and zygote genome editing workflows. Beyond instrumentation, the company offers oligo DNA/RNA synthesis, peptide synthesis, antibody production, gene analysis, STR-based cell authentication, protein expression, plasmid preparation, and other contract research services. BEX appears to serve universities, research institutes, and private-sector bioscience customers rather than operating as a therapeutic drug developer. The company is therefore best characterized as an active commercial life science tools and services provider with a strong focus on electroporation-enabled genome engineering and related laboratory workflows.